Objectives: The use of thoracic endovascular aortic repair (TEVAR) for chronic DeBakey III type b (CDIIIb) aneurysms is controversial. We analyzed the potential prognostic factors affecting aorta remodeling after this procedure.
Conclusions: Although reentry tears above the celiac trunk were fully covered, the visceral branches and ICAs from the FL and all communicating channels below the celiac trunk kept the FL pressurized and were unfavorable prognostic factors for aorta remodeling after TEVAR for CDIIIb aneurysms. (J Thorac Cardiovasc Surg 2014;148:925-33) Supplemental material is available online.
The ideal treatment of patients with chronic DeBakey III (CDIII) aortic dissections remains controversial. The optimal medical therapy of anti-impulse treatment has been used in most patients, and selective open or endovascular repair has been used for complicated chronic cases, such as those involving aneurysmal degeneration, malperfusion, persistent pain, or rupture. Although recent series have suggested thoracic endovascular aortic repair (TE-VAR) as a promising treatment of acute, complicated type B aortic dissections, 1,2 outcome studies of TEVAR-treated CDIII aneurysms have been primarily retrospective, single-center experiences involving heterogeneous cohorts with various operative indications and different strategies.
Open surgery for CDIII aneurysms has been associated with substantial morbidity and mortality. 3, 4 In light of the success of TEVAR in patients with degenerative aneurysms, this therapy offers an attractive alternative to open surgery for CDIII aneurysms. 5, 6 However, several issues also mitigate against the use of TEVAR in these patients. The presence of a mature, rigid dissection flap, and multiple reentry tears have been thought to potentiate failure of endovascular therapy, and the long-term durability of endovascular management remains uncertain. 7 The primary aim of managing CDIII aneurysms is to avoid death from aortic rupture. This clinical endpoint has frequently been associated with the ability of TEVAR to trigger favorable aortic remodeling, an important outcome predictor of false lumen (FL) patency. 8, 9 Although the results of TEVAR for CDIII type a (CDIIIa) aneurysms have been exciting, concerns regarding the use of this technique in patients with CDIII type b (CDIIIb) aneurysms remain, including concerns about the precipitation of retrograde dissection or visceral ischemia. 10, 11 The present study investigated the prognostic factors for aorta remodeling after TEVAR for complicated CDIIIb aneurysms.
METHODS

Patient Population
The institutional review board at the Gangnam Severance Hospital, Yonsei University College of Medicine (Yonsei institutional review board no. 3-2012-0259) approved the present study. A prospectively maintained endovascular aortic registry was queried for all patients undergoing TE-VAR from May 2012 to April 2013.
Patients treated for degenerative and trauma-related pathologic entities (including aneurysms, penetrating ulcers, atheromatous disease, pseudoaneurysms, and traumatic transections) were excluded. Patients with dissection-related indications were reviewed further, and only those undergoing elective procedures for chronic (>3 months after the diagnosis of acute aortic dissection) aneurysmal degeneration of descending aortic dissections extending to the abdominal aorta (CDIIIb) were included. The patients with dissecting aneurysms confined to the descending thoracic aorta (CDIIIa) were excluded. Although acute proximal dissections were not included, patients previously treated for type A dissections who had residual CDIIIb aneurysms were included. The indications for TEVAR included newly developed, continuing back pain, and aneurysmal degeneration (maximal thoracic aneurysm diameter ! 5.5 cm or a documented growth rate of 0.5 cm within 6 months seen on serial computed tomography angiograms [CTA] ). The demographics, comorbidities, procedure-specific details, reinterventions, and complications were collected from the medical records.
Clinical Practice
A standardized treatment algorithm was used throughout the study period for patient selection and procedural conduct. All operations were performed electively with the patient under general anesthesia in a hybrid operating room. The need for perioperative adjuncts (eg, spinal drainage, carotid-subclavian bypass, open or percutaneous vessel access) were at the discretion of the attending surgeon and interventional radiologist.
All patients received systemic heparin (100 U/kg) to achieve an activated clotting time of more than 300 seconds. Devices were oversized 10% to 15%, relative to the diameter of the undissected aorta proximal to the dissection, using tapered stent grafts. At the beginning of study period, the distal landing zone was in the mid-descending thoracic aorta (group 3). However, for the remaining cases, the coverage length was selected to exclude the entire dissected thoracic aorta and all fenestrations (group 2). Our current practice has been for more aggressive aortic coverage (ie, we generally treat down to the celiac artery in patients with juxtaceliac fenestrations (group 1; Figure 1) . In some cases, we have covered the celiac trunk, when backflow from the superior mesenteric artery was expected. Technical success was defined as endograft deployment at the intended aortic segment, with the absence of antegrade flow into the FL. Compliant balloon angioplasty of the proximal stent graft was selectively performed only in the event of type Ia endoleaks. Spinal cord ischemia (SCI) was defined as any new lower extremity motor and/or sensory deficit not attributable to intracranial pathologic features, peripheral neuropathy, or neuropraxia. The diagnosis was determined by the treating physician and confirmatory imaging.
Degree of FL Thrombosis
The degree of FL thrombosis was analyzed using precontrast, arterial, and delayed phases of postoperative CTA (3-mm-thick axial slices). It was classified as partial thrombosis if both flow and thrombus were present and as complete thrombosis if no flow was present at the level of the stent graft. 12 
Remodeling Analysis
Aorta remodeling after TEVAR was analyzed, as shown in Figure E1 . The preoperative FL diameter was marked as ''a,'' and the postoperative FL diameter was marked as ''b.'' The measurements of ''a'' and ''b'' were performed at the level of the maximal descending thoracic aortic aneurysm. We sought to find risk factors affecting the FL ratio (b/a). If >2 CT scans had been performed after hospital discharge, the most recent image was used to determine the ratio. If an aortic segment had been subjected to repeated aortic procedures, the patient was excluded from additional FL diameter assessments. Postoperative surveillance was determined using a protocol of imaging before discharge, at 3 and 6 months after discharge, and annually thereafter. We also analyzed the relationship of the degree of FL thrombosis with the FL ratio.
Anatomic Factors
The maximum diameters of the thoracic aorta, thoracic FL, abdominal aorta, and abdominal FLs were measured on the preoperative CTAs. The following parameters were measured during postoperative CTAs before patient discharge by 2 experienced vascular radiologists: residual reentry tears were counted below the stent graft; large intimal tears were counted, as seen in !2 CTA axial cuts below the stent graft; the numbers of intercostal arteries (ICAs) and visceral arteries from the FL were counted; and the maximum diameters of the FLs were determined at the last follow-up CTAs.
Statistical Analysis
The categorical variables were summarized using frequencies and percentages. Continuous variables were analyzed using the mean and standard deviations, if they were normally distributed. Comparisons of patient-or procedure-related characteristics in subgroup analyses were performed using Fisher's exact tests or independent t tests. Variables with P<.1 on univariate analysis were included in the multivariate model, which was refined using stepwise backward binary logistic regression. The relationship between the FL ratios and patient variables was analyzed using Spearman's rank correlation and linear regression analysis. All statistical analyses were performed using the Statistical Package for Social Sciences, version 20, software (SPSS, Chicago, Ill).
RESULTS
The Gangnam Severance TEVAR registry (n ¼ 103) identified 20 patients (19%), who had undergone elective TEVAR for the treatment of CDIIIb aneurysms from May 2012 to April 2013. The mean interval from the diagnosis of the acute dissection to TEVAR was 18.1 AE 11.9 months (range, , and the mean follow-up duration was 10.3 AE 4.9 months (range, 5-15). Ten patients (50%) who had undergone surgery for acute type A dissections had large tears at the proximal descending thoracic aorta because they had had retrograde type A dissections or multiple tears.
Procedural Details and Perioperative Outcomes
A total of 30 stent grafts were deployed in 20 patients, including the Zenith TX2 Proform (Cook, Bloomington, Ind) in 17 patients and the Valiant Captivia (Medtronic, Minneapolis, Minn) in 3 patients. Eleven patients (55%) needed 1 stent graft, 8 (40%) needed 2, and 1 (5%) needed 3.
Primary technical success, defined as the successful closure of the primary tear without a type Ia endoleak, was achieved in all cases. None of the patients required conversion to open surgery. Preoperatively placed spinal drains were used in 13 patients (65%).
In 11 patients (55%), coverage occurred at Ishimaru zones 1 or 2, 13 and all these patients underwent subclavian revascularization with or without a carotid-carotid bypass. The distal landing zone was group 1 or 2 in almost all patients (n ¼ 18, 90%; Figure 1 ). All patients were treated with covered stent grafts. The mean hospital and intensive care unit stay was 7.5 days and 28.7 hours, respectively, without any in-hospital deaths or neurologic dysfunction. Additional details regarding the outcomes and complications are listed in Table 1 .
Degree of FL Thrombosis
Thirteen patients (65%) had complete thrombosis of the FL during the first postoperative CTA performed a mean of 28 days after TEVAR. Univariate analysis was used to evaluate the 14 parameters listed in Table 2 . Values of P<.1 were obtained for age at the interventional procedure, number of large intimal tears, number of visceral branches partially or totally arising from the FL, and maximum diameter of the aorta and the FL on the abdominal aorta; these were used in the multivariate analysis. Multivariate binary logistic regression analysis revealed that the number of large intimal tears (odds ratio, 11.30; 95% confidence interval, 1.16-110.40; P ¼ .037) was an independent risk factor for partial thrombosis. When we focused on the anatomic characteristics of the dissections and compared them with those of the partial thrombosis group, the number of reentry tears, large intimal tears below the stent graft, visceral branches arising from the FL, and ICAs arising from the FL in the complete thrombosis group was 1.8 versus 2.3 (P ¼ .48), 0.8 versus 1.7 (P <.05), 1.2 versus 2.3 (P <.05), and 3.8 versus 5.1 (P ¼ .35), respectively ( Table 2) .
Remodeling Analysis
Remodeling analysis was performed with the FL ratio using the preoperative CTA and last CTA (4.7 months after TEVAR). Univariate linear regression analysis revealed that age, number of reentry tears, visceral branches and FIGURE 1. Schematic diagram of anatomic factors affecting false lumens after thoracic endovascular aortic repair. Groups were classified according to the distal landing zone: group I, covered to the celiac trunk; group II, whole descending thoracic aorta; group III, mid-descending thoracic aorta. I, Intercostal artery from the false lumen; D, diaphragm; L, large intimal tear; R, reentry tear; V, visceral branch from the false lumen.
ICAs from the FL, and preoperative thoracic FL diameters were significant negative prognostic factors predicting FL shrinkage (P <.05). Multivariate linear regression analysis revealed that age (P ¼ .015) and the number of visceral branches and ICAs from the FL (P ¼ .002) were independent risk factors for FL shrinkage (Table 3 ; Figure 2 ). The FL ratio of the complete thrombosis group was significantly lower than that of the partial thrombosis group. (0.70 AE 0.14 vs 0.82 AE 0.07, P ¼ .035; Table 2 ). The difference in the shrinkage of the descending thoracic aorta, abdominal aorta, and abdominal FL was not significant (P >.05).
Reintervention
Reintervention was defined as any aortic-related endovascular or open surgical procedure that occurred after the index TEVAR at either the intended treatment zone or remote aortic sites. Two patients (10%; group 3; Figure 2 ), at the beginning of the present study, had experienced stent graft-induced new intimal tears at 5 months and 1 year after TEVAR, respectively, and had undergone additional TEVAR.
DISCUSSION
The aim of postaortic dissection TEVAR is to cover the primary entry tear, thereby initiating FL thrombosis and aortic remodeling. Although inconclusive, mounting evidence has suggested that aortic remodeling is significantly associated with improved midterm survival and that persistent FL perfusion is associated with disease progression. [14] [15] [16] Favorable aortic remodeling usually begins within days after TEVAR for acute aortic dissection and continues for 5 years. 17 However, patients with CDIII aneurysms have greater variations in the rate of complete FL thrombosis. 14 Several explanations have been proposed for this variation. First, according to the current definition, ''chronic'' dissections include those that have been present for >2 weeks, creating significant diversity among individuals within the classification. The INvestigation of STEnt Grafts in Aortic Dissection trial, reporting a total FL thrombosis rate of 92.6% at 1 year, enrolled patients at a median of 3.5 weeks after the diagnosis of acute aortic dissection. 2 In contrast, the study with the lowest rate of FL thrombosis (39%) treated patients at a mean of 100 weeks after diagnosis, 18 even after 3 years of follow-up. The difference between these 2 studies suggests the classification of aortic dissections as ''acute'' or ''chronic'' is insufficient; the ''subacute'' classification described in the VIRTUE study (2-4 weeks after the acute event) might be more clinically relevant. 19 In our study, we defined ''chronic'' as >3 months after the diagnosis of acute aortic dissection. 20 Second, many reports have described data using mixed populations with varying disease extents. In patients with CDIIIb aneurysms, involving persistent distal FL perfusion, aorta remodeling has been more difficult than in CDIIIa aneurysms. Rodriguez and colleagues 8 reported complete thrombosis of the thoracic FL in 64% of CDIIIa aneurysms and 45% of CDIIIb aneurysms after TEVAR. We only enrolled patients with CDIIIb aneurysms. Third, perioperative practices can change over time or among centers. 21, 22 Fourth, a standardized reporting system does not exist, including a lack of consensus regarding definitions of clinical success and concerns about treatment failure. Most reports have focused on FL thrombosis and have relied on the arterial phase of CTA to determine the treatment effect. However, FL can persist in the delayed phase. The absence of contrast in the delayed phase does not indicate thrombosis but denotes a low-flow state. In the present study, we used both the arterial and 3-minute delayed phase; the delayed phase image altered the FL status in 7 cases (35%) ( Figure E2 ). As evident from these various reports, the reasons for variation in the rates of complete FL thrombosis arise from several sources of cohort heterogeneity. In our study, we aimed for greater patient homogeneity to describe a universal outcome for patients with CDIIIb aneurysms.
The possible mechanisms for persistent FL perfusion include distal reentry tears, retrograde filling flows into the FL, and motion of the dissection flap. 11 The first mechanism suggests that reentry segments, distal to the stent graft, can provide retrograde perfusion into the thoracic FL and antegrade perfusion into the abdominal FL. Our treatment strategy covers all tears in the descending thoracic aorta to the celiac trunk level to accelerate thrombus formation in the FL. However, this goal is difficult to achieve, particularly in patients with multiple reentry tears located in the abdominal aorta. Multiple tears are commonly seen in CDIIIb aneurysms; !1 tear, distal to the orifice of the celiac artery, was present in 62% of patients in 1 report, 23 and an average of 2.8 intimal tears was found in another series, 24 allowing continued FL perfusion after TEVAR. In the present study, the primary entry tear was sealed by the stent graft in all patients, and a mean of 3.1 tears (reentry tears, 2.0; large intimal tears, 1.1) remained below the stent graft. The number of large intimal tears found using CTA 4 weeks after TEVAR was selected as a parameter for analysis and was a significant risk factor associated with partial thrombosis in the FL (P ¼ .037). The second mechanism proposes retrograde filling perfusion of the FL by way of the ICAs or visceral branches originating from the FL. Visceral branches solely supplied by the FL in extensive type B dissections were first emphasized by Dinsmore and colleagues. 25 They proposed that if vital organs did not depend on the FL for their blood supply, complete FL occlusion tended to occur. Others 26 have reported that the visceral branches that arose partially or totally from the FL were risk factors for partial thrombosis in acute DeBakey IIIb aortic dissection. To date, no report has been published about ICAs affecting aorta remodeling. The present study revealed that the number of visceral branches and ICAs arising partially or totally from the FL was an independent risk factor associated with FL shrinkage (P ¼ .002) at 4.7 month after TEVAR. The results from our study suggested the first mechanism would affect the early phase of aortic remodeling, and the second mechanism would affect aortic remodeling after the period.
Regarding the third mechanism, the role of intimal flap motion was recently analyzed in another report. 27 Unimpeded septal motion could conceivably prevent flow stagnation and thrombosis in the aortic FL. The present study revealed the younger age was an important risk factor for FL shrinkage 4.7 months after TEVAR (P ¼ .015). This was because the elderly would have more restricted septal motion than would younger patients.
With our TEVAR strategy for CDIIIb aneurysms, extending the stent graft to the level of the celiac trunk, all reentry tears in the descending thoracic aorta were completely covered. This strategy resulted in complete FL thrombosis at the stent graft level in 13 patients (65%) during a mean follow-up duration of 28 days. Furthermore, FL thrombosis occurred more frequently in patients with fewer residual reentry tears below the level of the stent graft and in those with fewer ICAs and visceral arteries from the FL. However, the level of the distal stent graft was not associated with FL thrombosis or aorta remodeling. Although we expected the more distal landing zone would result in more complete FL thrombosis, the rate was only 37.5% in group 1 compared with 80% in group 2 in our study (Table E1 ). This unexpected result suggests that the level of the distal stent graft itself is not associated with the FL thrombosis. Rather, the anatomic factors such as the number of reentry tears, large intimal tears, ICAs from the FL, and visceral branches from the FL would be more important for the outcome after TEVAR in patients with CDIIIb aneurysms.
Additional Concerns
The potential for endograft collapse, stent graft-induced new intimomedial erosions, and retrograde aortic dissections are additional concerns regarding TEVAR management of CDIIIb aneurysms.
14 Despite the frequent presence of small, distal, true lumens and rigid septa, we did not observe endograft collapse, perhaps because we used tapered grafts for the distal true lumens. Two patients experienced new, stent graft-induced intimal tears. Excessive oversizing of the distal stent graft could be a significant risk factor with regard to late distal intimomedial erosion. 28 After those cases, we stopped using excessive oversizing and did not deploy stent grafts at the mid-descending thoracic aorta level. Similarly, retrograde dissections, reported in 4% of other cases, 14 did not occur in the present series. These events underscore the limitations of the current stent graft designs for chronic dissections. In most cases, treatment extended to the left common carotid artery, and the endograft must adapt to significant differences in lumen diameters between the proximal and compressed distal true lumens. The next generation of stent graft design will likely have pathology-specific modifications to address these challenges. 29 The most dreaded complication of TE-VAR for CDIII aneurysm management is SCI. When we decide the level of distal landing zone, we should assess the balance between the benefit of complete FL thrombosis, and the risk of SCI. Although we aggressively manage CDIIIb aneurysms at our institution, deploying the stent grafts above the celiac trunk level, SCIs have not occurred. Of note, we use a protocol involving liberal use of cerebrospinal fluid drainage and subclavian revascularization.
Study Limitations
The present report had several important limitations. 15 defined aorta remodeling as a >0.5 cm reduction in the maximum descending thoracic aorta diameter from preoperative imaging to the final follow-up imaging study. However, we used the degree of FL thrombosis and FL ratio as surrogate markers for aorta remodeling. A consensus on more accurate classification and definition could help to determine the most appropriate method of treating chronic dissection in terms of the timing and extent of aortic coverage. 20 Third, the number of patients was very small, and the follow-up duration was too short to draw conclusions regarding the aorta remodeling process and survival analysis. However, we confirmed that the period for FL thrombosis could be as short as 4 weeks and that FL regression occurred at around 3 to 6 months after TEVAR. Fourth, although postoperative CTA was available for all patients, only 2 points were analyzed to discern FL thromboses and diameters. Moreover, multilevel and volumetric data were not abstracted, which might have offered a more comprehensive and precise assessment of aortic remodeling for dissection-related pathologic features. 16 FL patency status was determined using the 3 phases of postoperative CTA, and this might may not be the most sensitive or specific method for analyzing this endpoint, given the reports describing the efficacy of various dynamic magnetic resonance imaging techniques. 27 
CONCLUSIONS
TEVAR for CDIIIb aneurysms ensures a high degree of technical success and results in acceptable perioperative morbidity and mortality. SCI can be prevented with the liberal use of spinal drainage and subclavian revascularization. Although all reentry tears were fully covered above the celiac trunk, the visceral branches and ICAs from the FL and visible communicating channels below the celiac trunk will keep the FL pressurized and are unfavorable prognostic factors of aorta remodeling after TEVAR for CDIIIb aneurysms.
My 2 questions are, first, at the time of deployment of the endograft, was that recognized, and if so, was it addressed at the time? Also, if it has not been addressed, are you planning to follow-up on this endoleak with another study to see whether other measures have eliminated it or not? Dr Song. Thank you for your excellent questions. However, very few reports have been published about type II endoleaks for chronic type III aortic dissections.
In a case with acute type B dissections, 1 study commented on the visceral branches for the backflow from the visceral branch to the FL. However, as far as I know, no report has yet been published about ICAs from the FL that make retrograde backflow to fill the FL and prevent FL thrombosis. I think it is very difficult to know if a type II endoleak from the ICAs is present at intervention. Also, I cannot tell you about the type II endoleak, which is a terminology frequently used with the degenerative aneurysm, because the pathologic features are clearly different between chronic IIIb aneurysm and degenerative aneurysm.
Dr Sherif. Thanks for the presentation.
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